Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven) after allogenic bone marrow transplantation.
Karimi
M
M
Zakerinia
M
M
Khojasteh
H N
HN
Ramzi
M
M
Ahmad
E
E
D000328:Adult; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage*; D003556:Cystitis / Q000188:drug therapy* / Q000209:etiology; D004341:Drug Evaluation; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D005260:Female; D006402:Hematologic Diseases / Q000150:complications / Q000628:therapy; D006470:Hemorrhage / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use*; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D011994:Recombinant Proteins; D003520:Cyclophosphamide; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa